Bioventus
BVS
BVS
132 hedge funds and large institutions have $329M invested in Bioventus in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 39 increasing their positions, 49 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 133 → 132 (-1)
20% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 49
48% less call options, than puts
Call options by funds: $350K | Put options by funds: $669K
Holders
132
Holding in Top 10
3
Calls
$350K
Puts
$669K
Top Buyers
| 1 | +$4.35M | |
| 2 | +$3.54M | |
| 3 | +$2.9M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.12M |
| 5 |
Jane Street
New York
|
+$1.84M |
Top Sellers
| 1 | -$3.77M | |
| 2 | -$2.74M | |
| 3 | -$2.58M | |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$1.87M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$956K |
